Header Image
CTx-1301 for ADHD

CTx-1301 for ADHD

CTx-1301 is dexmethylphenidate in a three-step extended-release formulation.
CTx-1301 is said to offer up to 16 hours of efficacy with once-daily dosing.

Initial Phase III studies are said to have reported strong efficacy and tolerability.1
We have not yet been able to find any reports of such studies.

Diese Seite wurde am 06.04.2026 zuletzt aktualisiert.